Do analysts rate SXTPW or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 60 Degrees Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, SXTPW or SISI?

60 Degrees Pharmaceuticals has higher earnings, but lower revenue than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 60 Degrees Pharmaceuticals $1.11M N/A N/A N/A N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Do analysts recommend BFRIW or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biofrontera 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, BFRIW or SISI?

Biofrontera has higher revenue and earnings than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $46.18M N/A N/A N/A N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Is BFRIW or SISI more profitable?

Biofrontera has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Biofrontera's return on equity of 0.00% beat Shineco's return on equity. Company Net Margins Return on Equity Return on Assets Biofrontera N/A N/A N/A Shineco -380.55% -79.89% -33.01%

Do analysts recommend SISI or CALA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Calithera Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation & earnings, SISI or CALA?

Shineco has higher revenue and earnings than Calithera Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shineco $9.60M 0.00 -$22.45M -$204.00 N/A Calithera Biosciences N/A N/A -$39.65M N/A N/A

Do analysts prefer CINGW or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cingulate 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, CINGW or SISI?

Cingulate has higher earnings, but lower revenue than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cingulate N/A N/A N/A N/A N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Is CINGW or SISI more profitable?

Cingulate has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Cingulate's return on equity of 0.00% beat Shineco's return on equity. Company Net Margins Return on Equity Return on Assets Cingulate N/A N/A N/A Shineco -380.55% -79.89% -33.01%

Do analysts rate CLVR or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clever Leaves 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, CLVR or SISI?

Clever Leaves has higher revenue and earnings than Shineco. Clever Leaves is trading at a lower price-to-earnings ratio than Shineco, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Clever Leaves $17.42M 0.00 -$17.90M -$9.66 N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Is CLVR or SISI more profitable?

Clever Leaves has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Clever Leaves' return on equity of 0.00% beat Shineco's return on equity. Company Net Margins Return on Equity Return on Assets Clever Leaves N/A N/A N/A Shineco -380.55% -79.89% -33.01%

Shineco (SISI) Competitors

$0.0003 0.00 (0.00%)

As of 09/2/2026

Compare

SISI vs. SXTPW, BFRIW, CALA, CINGW, and CLVR

Should you buy Shineco stock or one of its competitors? Shineco's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Clever Leaves (CLVR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Shineco compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Shineco (NASDAQ:SISI) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Shineco. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Shineco. 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat Shineco's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
60 Degrees Pharmaceuticals	Very Positive
Shineco	Neutral

4.1% of Shineco shares are owned by institutional investors. 0.0% of Shineco shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

60 Degrees Pharmaceuticals has higher earnings, but lower revenue than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$1.11M	N/A	N/A	N/A	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
60 Degrees Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

60 Degrees Pharmaceuticals has a net margin of 0.00% compared to Shineco's net margin of -380.55%. 60 Degrees Pharmaceuticals' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

Summary

60 Degrees Pharmaceuticals beats Shineco on 5 of the 9 factors compared between the two stocks.

How does Shineco compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Shineco (NASDAQ:SISI) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation.

4.1% of Shineco shares are held by institutional investors. 0.0% of Shineco shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Biofrontera has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Biofrontera's return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biofrontera	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Biofrontera has higher revenue and earnings than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$46.18M	N/A	N/A	N/A	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Shineco'saverage media sentiment score.

Company	Overall Sentiment
Biofrontera	Neutral
Shineco	Neutral

Summary

Biofrontera beats Shineco on 4 of the 7 factors compared between the two stocks.

How does Shineco compare to Calithera Biosciences?

Shineco (NASDAQ:SISI) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

Shineco has a beta of -1.61, indicating that its share price is 261% less volatile than the broader market. Comparatively, Calithera Biosciences has a beta of -1.23, indicating that its share price is 223% less volatile than the broader market.

In the previous week, Shineco's average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.

Company	Overall Sentiment
Shineco	Neutral
Calithera Biosciences	Neutral

4.1% of Shineco shares are owned by institutional investors. 0.0% of Shineco shares are owned by company insiders. Comparatively, 6.6% of Calithera Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Calithera Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Shineco has higher revenue and earnings than Calithera Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A
Calithera Biosciences	N/A	N/A	-$39.65M	N/A	N/A

Calithera Biosciences has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Calithera Biosciences' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shineco	-380.55%	-79.89%	-33.01%
Calithera Biosciences	N/A	N/A	N/A

Summary

Shineco and Calithera Biosciences tied by winning 5 of the 10 factors compared between the two stocks.

How does Shineco compare to Cingulate?

Cingulate (NASDAQ:CINGW) and Shineco (NASDAQ:SISI) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

Cingulate has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Cingulate's return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cingulate	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

4.1% of Shineco shares are owned by institutional investors. 0.0% of Shineco shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cingulate has higher earnings, but lower revenue than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cingulate	N/A	N/A	N/A	N/A	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Shineco'saverage media sentiment score.

Company	Overall Sentiment
Cingulate	Neutral
Shineco	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cingulate	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Shineco beats Cingulate on 4 of the 7 factors compared between the two stocks.

How does Shineco compare to Clever Leaves?

Clever Leaves (NASDAQ:CLVR) and Shineco (NASDAQ:SISI) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled Shineco'saverage media sentiment score.

Company	Overall Sentiment
Clever Leaves	Neutral
Shineco	Neutral

Clever Leaves has a beta of 3845.97, indicating that its stock price is 384,497% more volatile than the broader market. Comparatively, Shineco has a beta of -1.61, indicating that its stock price is 261% less volatile than the broader market.

6.9% of Clever Leaves shares are owned by institutional investors. Comparatively, 4.1% of Shineco shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by insiders. Comparatively, 0.0% of Shineco shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Clever Leaves has higher revenue and earnings than Shineco. Clever Leaves is trading at a lower price-to-earnings ratio than Shineco, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clever Leaves	$17.42M	0.00	-$17.90M	-$9.66	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

Clever Leaves has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Clever Leaves' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clever Leaves	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clever Leaves	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Clever Leaves beats Shineco on 10 of the 12 factors compared between the two stocks.

Get Shineco News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SISI vs. The Competition

Export

Metric	Shineco	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$12.25B	$7.26B	$12.73B
Dividend Yield	N/A	2.59%	2.53%	8.86%
P/E Ratio	0.00	787.27	273.29	25.25
Price / Sales	0.00	755.95	621.79	97.64
Price / Cash	N/A	94.80	77.82	52.26
Price / Book	0.00	12.31	13.08	6.14
Net Income	-$22.45M	$2.82B	$3.47B	$349.01M
7 Day Performance	N/A	2.59%	0.52%	-0.31%
1 Month Performance	N/A	6.95%	5.63%	0.64%
1 Year Performance	N/A	9.44%	25.31%	14.83%

Shineco Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SISI Shineco	N/A	$0.00 flat	N/A	-100.0%	$0.00	$9.60M	N/A	70
SXTPW 60 Degrees Pharmaceuticals	N/A	$0.04 +55.7%	N/A	-62.0%	$0.00	$1.11M	N/A	2	News Coverage Positive News
BFRIW Biofrontera	N/A	$0.03 flat	N/A	-83.7%	$0.00	$46.18M	N/A	70	Positive News Gap Up
CALA Calithera Biosciences	N/A	$0.00 +200.0%	N/A	+200.0%	$0.00	N/A	N/A	60
CINGW Cingulate	N/A	$0.01 -31.6%	N/A	-84.3%	$0.00	N/A	N/A	20	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SISI) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shineco (SISI) Competitors

SISI vs. SXTPW, BFRIW, CALA, CINGW, and CLVR

How does Shineco compare to 60 Degrees Pharmaceuticals?

Summary

How does Shineco compare to Biofrontera?

Summary

How does Shineco compare to Calithera Biosciences?

Summary

How does Shineco compare to Cingulate?

Summary

How does Shineco compare to Clever Leaves?

Summary

Media Sentiment Over Time

SISI vs. The Competition

Shineco Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shineco (SISI) Competitors

SISI vs. SXTPW, BFRIW, CALA, CINGW, and CLVR

How does Shineco compare to 60 Degrees Pharmaceuticals?

Does the media refer more to SXTPW or SISI?

Do insiders & institutionals hold more shares of SXTPW or SISI?

Which has higher earnings & valuation, SXTPW or SISI?

Do analysts rate SXTPW or SISI?

Is SXTPW or SISI more profitable?

Summary

How does Shineco compare to Biofrontera?

Do institutionals and insiders hold more shares of BFRIW or SISI?

Is BFRIW or SISI more profitable?

Do analysts recommend BFRIW or SISI?

Which has stronger earnings & valuation, BFRIW or SISI?

Does the media refer more to BFRIW or SISI?

Summary

How does Shineco compare to Calithera Biosciences?

Which has more volatility & risk, SISI or CALA?

Does the media refer more to SISI or CALA?

Do institutionals & insiders believe in SISI or CALA?

Do analysts recommend SISI or CALA?

Which has preferable valuation & earnings, SISI or CALA?

Is SISI or CALA more profitable?

Summary

How does Shineco compare to Cingulate?

Is CINGW or SISI more profitable?

Do institutionals and insiders hold more shares of CINGW or SISI?

Which has better valuation & earnings, CINGW or SISI?

Does the media prefer CINGW or SISI?

Do analysts prefer CINGW or SISI?

Summary

How does Shineco compare to Clever Leaves?

Does the media prefer CLVR or SISI?

Which has more risk and volatility, CLVR or SISI?

Do insiders and institutionals hold more shares of CLVR or SISI?

Which has preferable valuation & earnings, CLVR or SISI?

Is CLVR or SISI more profitable?

Do analysts rate CLVR or SISI?

Summary

Media Sentiment Over Time

SISI vs. The Competition

Shineco Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools